Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01678300 · ClinicalTrials.gov registry record
Qualitative Study of Topical Mesalamine Adherence in Patients With Ulcerative Colitis(UC)
A clinical trial, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- 70
- Enrollment target
NCT01678300: Completed study, sponsored by Beth Israel Deaconess Medical Center.
NCT01678300 is a clinical trial that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 70 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01678300 has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- 70 participants
- Enrollment target
Study Summary
The purpose of this protocol is: 1. To quantify the prevalence of adherence to topical mesalamine in patients with UC 2. To describe the determinants of medication adherence in patients with UC prescribed topical mesalamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2012-08 |
| Est. Completion | 2015-11 |
What the finished NCT01678300 record still lists
NCT01678300 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 70 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01678300 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01678300 about?
NCT01678300 is a clinical study titled "Qualitative Study of Topical Mesalamine Adherence in Patients With Ulcerative Colitis(UC)". The purpose of this protocol is: 1. To quantify the prevalence of adherence to topical mesalamine in patients with UC 2. To describe the determinants of medication adherence in patients with UC prescribed topical mesalamine
What is the current status of trial NCT01678300?
This trial is currently completed. The enrollment target is 70 participants. The study started on 2012-08. Estimated completion is 2015-11.
Who is sponsoring clinical trial NCT01678300?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia